Dermeze

Quick links to important sections

Dermeze

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dermeze

Property Description
Active ingredient White Soft Paraffin, Liquid Paraffin
Form Ointment, Cream
Pharmacological class Emollient, Occlusive Skin Protectant
Common use Intensive moisturizing for very dry skin
Origin Synthetic/Derived (Petroleum-based)

Dermeze is an Over-The-Counter (OTC) topical pharmaceutical preparation formally classified as an emollient and occlusive skin protectant, and is clinically recognized for its high level of skin tolerance. It is a combination product distinguished by its simple, highly purified formulation based on hydrocarbon components, minimizing the risk of irritation often associated with fragrances or preservatives. Occlusive agents like paraffin are essential for maximizing water retention in the stratum corneum. This mechanism helps sustain the skin's moisture levels by forming a protective seal.

The Core Composition: Paraffin Ingredients and Forms

The primary Active ingredients / Chemical substances in Dermeze are White Soft Paraffin (Petrolatum) and Liquid Paraffin (Mineral Oil), which are synthetic/derived semisolid hydrocarbons. This blend is specifically formulated to be suitable for highly sensitive skin, representing a key differentiation factor from general-purpose moisturizers. Petrolatum is widely used to prevent or temporarily relieve dryness and minor skin irritations. This use highlights the preparation's core identity as a simple, highly tolerant protective agent. The product is provided in various Drug forms / Pharmaceutical preparations, commonly including a dense Ointment and a lighter Cream to suit different levels of dryness and target patient groups.

General Purpose and Action for the Skin Barrier

The general purpose of Dermeze is to provide intensive, physical relief for dry skin conditions by reinforcing the epidermal barrier. The Physiological actions are purely physical: creating an effective occlusive sealing layer over the skin to prevent Transepidermal Water Loss (TEWL). This mechanism facilitates essential moisture retention within the tissue. This action contributes to soothing the skin and reducing the roughness and flaking associated with chronic dehydration, making it a well-established support tool for damaged skin barrier function.

Regulatory References

  1. Petrolatum - PubChem - NIH
  2. Atopic dermatitis - MedlinePlus Medical Encyclopedia
  3. Petrolatum Cream - DailyMed (NIH)

What side effects are possible with Dermeze?

Possible Side Effects and Safety Information

The safety profile of Dermeze, which contains White Soft Paraffin and Liquid Paraffin, is characterized by a low incidence of pharmacological adverse reactions, with the most significant safety concern being non-pharmacological. All safety information is consistent with official regulatory documents.


Officially Documented Adverse Reactions

The documented adverse reactions are primarily limited to the application site, classified according to standard regulatory frequency categories:

Classification Type of Adverse Reaction
Rare (1 in 1,000 to 1 in 10,000) Local application site reactions (e.g., pruritus, erythema, rash, skin burning sensation), Hypersensitivity reactions.
Not Known Acne, Folliculitis

These effects fall under the Skin and Subcutaneous Tissue Disorders System-Organ-Class. Due to negligible systemic absorption of the active ingredients when applied topically, the risk of systemic adverse effects is considered minimal.


Safety Constraints and Special Populations

Serious Adverse Reactions: No reaction is consistently classified as pharmacologically serious. However, regulatory authorities mandate warnings concerning a Severe Fire Hazard associated with the product.

Fire Hazard Restriction: The paraffin ingredients can contaminate clothing, bedding, and dressings, making them burn more easily and intensely when exposed to a naked flame. Patients are explicitly restricted from smoking or going near naked flames while using the product due to the risk of severe burns.

Population-Specific Notes: Safety statements regarding use during pregnancy indicate no effects are anticipated due to the negligible systemic exposure. For lactation, application to the breast is not recommended immediately prior to breastfeeding to prevent direct infant ingestion.

Overdose and Emergency Response

The official regulatory documentation for paraffin-based emollients, such as Dermeze, defines the primary overdose risk as accidental oral ingestion, as severe systemic toxicity from topical overuse is not described in labeling.

Overdose Manifestations and Complications

Manifestations following ingestion are documented as primarily affecting the gastrointestinal system. These presentations may include abdominal pain, nausea, vomiting, and constipation. A more serious documented complication is the potential for intestinal obstruction following the ingestion of a large amount. Regulatory information also notes that if the product contains certain inactive ingredients, a severe allergic reaction may occur, potentially leading to trouble breathing.

Emergency Action Required

The governmental guidance on emergency response is explicit: If swallowed, get medical help or contact a Poison Control Center right away. Immediate medical attention is required in all cases of accidental ingestion due to the risk of serious complications. Furthermore, urgent help must be sought if signs of a severe allergic reaction develop, such as wheezing or difficulty breathing.

Management and Monitoring

Treatment for overdose is symptomatic and supportive. The regulatory profile confirms that no specific antidote is available for this class of substance. Management procedures in the emergency setting include measuring and monitoring vital signs. Diagnostic monitoring, such as blood and urine tests, Chest x-ray, and ECG, may also be required as part of the official supportive care procedures.

Therapeutic Uses of Dermeze

What Dermeze Treats: Main Uses and Benefits

Dermeze is a topical preparation that leverages the highly occlusive properties of its core ingredients (Paraffins) to provide essential supportive therapy for conditions defined by a severely compromised and chronically dry skin barrier. This role establishes its therapeutic function as a skin protectant.


Intensive Management of Symptom Domains

This preparation is primarily used to address the symptomatic discomfort of severe and persistent skin dryness (xerosis) and conditions involving an irritated barrier, such as dermatitis, eczema, psoriasis, and ichthyosis. The therapeutic benefit supports intensive moisture retention and may assist in easing symptoms of dermal tightness, localized chapping, and deep roughness that arise from chronic dehydration. It is commonly used when symptoms interfere with daily functioning.

The product is relevant for managing pronounced symptomatic manifestations such as persistent itchiness (pruritus), excessive flaking, and visible scaling. By creating a physical seal and soothing the surface, Dermeze supports the management of the irritation that may lead to persistent itchiness and softening the skin.


Foundational Care and Stability

As an essential component of supportive care for recurrent conditions, this emollient provides non-pharmacological assistance during the maintenance phase. This sustained, high-level protection assists with maintaining functional stability against external irritants and supports skin stability, which is vital for patients managing long-term, recurrent skin diseases.

Quick Fact: Relief for Severe Dryness

Dermeze is generally applied when symptoms are marked by intense, chronic dryness and associated roughness, supporting the skin's need for continuous moisture and protection.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Dermeze?

The population eligibility profile for Dermeze, based on official regulatory documentation for its paraffin-based emollient formulation, confirms its suitability for a wide demographic.

General Eligibility Status

Population Official Eligibility Status
All Age Groups Use is approved for infants, children, adults, and the elderly.
Pregnancy Use is permitted as no adverse systemic effects are anticipated.
Systemic Conditions No specific contraindications are documented for patients with hepatic or renal impairment.

Absolute Non-Eligibility and Restrictions

The medicine is contraindicated for any individual with a documented hypersensitivity or allergy to White Soft Paraffin, Liquid Paraffin, or any other excipient in the product's formulation.

Use is also subject to specific restrictions regarding the skin's integrity at the application site:

  • Damaged Skin: Must not be applied to infected, weeping, broken, or severely damaged skin.
  • Lactation: Application to the breast area is not recommended for mothers who are breastfeeding to prevent potential ingestion by the infant.

This eligibility profile confirms broad use across demographics, with restrictions focusing solely on hypersensitivity and localized skin integrity.

What should I know about interactions with other medicines?

Interactions with other medicines and products — Official Regulatory Information

Official regulatory documentation establishes that Dermeze, being a highly inert topical product with negligible systemic absorption, has no documented pharmacokinetic (PK) interactions with orally administered or otherwise systemic medicinal products. This includes the absence of official statements regarding altered plasma exposure (AUC or C max) or influence on major metabolic pathways, such as the Cytochrome P450 enzyme system, or drug transporters.

The product's interaction profile is primarily defined by local, physical effects. The occlusive action, which forms a barrier on the skin surface, may physically impede the absorption or reduce the therapeutic effect of other topical medicinal products applied to the same area. Regulatory constraints therefore mandate a necessary timing separation between the administration of this emollient and other medicinal creams or ointments.

Furthermore, official government warnings document a serious hazard related to the product's paraffin components. When Dermeze soaks into fabric, dressings, or clothing, these materials become significantly more susceptible to ignition and can cause a rapid, intense fire if exposed to a naked flame or other ignition sources. This is classified as a critical drug-substance interaction hazard. No interactions with food, alcohol, or herbal products are officially documented.

Mechanism of Action

How Dermeze Works

The effect is achieved through a physicochemical mechanism that operates on the skin's surface, distinct from biochemical signaling pathways. Its action centers on creating an inert, physical barrier.

Physical Occlusion and TEWL Inhibition

The active ingredients, White Soft Paraffin and Liquid Paraffin, adhere to the Stratum Corneum (the outermost skin layer) to form a continuous, highly hydrophobic film. This physical coating forms a seal that restricts Transepidermal Water Loss (TEWL)—the natural evaporation of water vapor from the skin. The Stratum Corneum is the physical site of this interaction, which is characterized by adhesion and physical interposition, not receptor binding.

Passive Rehydration and Film Continuity

By reducing water escape, this mechanism causes the retention of endogenous water within the skin tissue. This leads to passive rehydration and swelling of the Stratum Corneum, altering the layer's plasticity. The blend of paraffins creates a barrier system, where the Liquid Paraffin assists the even spread of the White Soft Paraffin, influencing the continuity of the occlusive film across the surface.

Dosage and Administration Information

Administration and Application

The administration of Dermeze, an occlusive emollient based on White Soft Paraffin and Liquid Paraffin, follows a standard approach for skin protectants. Its use is strictly topical and designated for external use only, utilizing the available Ointment or Cream pharmaceutical forms. This route ensures the action is confined to the skin surface.

The application quantity is defined as a liberal amount, sufficient to create a continuous occlusive layer over the affected area, consistent with the principles of physically acting skin protectants. Application frequency is flexible, determined by the need to maintain constant skin barrier support. Use involves applying the product as often as needed, with standard administration patterns often involving application multiple times per day (e.g., three to five times daily) for intensive maintenance.

A key administration condition involves the timing of use: the preparation is applied to the skin after washing or bathing while the skin is still damp. This procedural step maximizes the occlusive mechanism by sealing in moisture. The product is suitable for application across all age groups, including infants, children, and older adults, reflecting its non-systemic administration. As supportive care, Dermeze is intended for continuous, long-term use to maintain the skin’s functional stability.

Recent Clinical Evidence

Research evidence / Overview of studies for Dermeze

Research into emollients like Dermeze focuses on their role as occlusive skin protectants to support the skin barrier, primarily through physical action. The evidence landscape includes data from randomized trials, long-term observational studies, and systematic reviews, which explore what has been observed so far in various dry skin conditions.


Evidence for Use in Severe Dry Skin (Xerosis)

This section summarizes the short-term physiological studies, including randomized trials, that have focused on measuring changes in skin hydration and water retention following the application of occlusive emollients.

Occlusive emollients like this one was studied for severe dry skin, known as xerosis. Research examined the preparation's immediate physical impact using short-term randomized trials and focused physiological assessments. In these studies, researchers monitored objective measurements, such as Transepidermal Water Loss (TEWL) and quantifiable changes in skin hydration using devices. Subjective patient reports related to skin roughness and flaking was also assessed.


Evidence for Use in Atopic Dermatitis (Eczema)

This part of the overview will summarize the systematic reviews and medium-to-long-term randomized controlled trials that have examined the role of these emollients as a foundational, supportive therapy in the management of Atopic Dermatitis.

The preparation was evaluated in research contexts involving fluctuating or unstable symptoms of Atopic Dermatitis (eczema). The evidence base includes systematic reviews, meta-analyses, and medium- to long-term randomized controlled trials that was evaluated in the context of adjunct therapy alongside standard treatments. Studies monitored outcomes related to physical discomfort, including validated composite disease severity scales and patient-reported measures of pruritus (itchiness).


Research Gaps and What Remains Uncertain about the Evidence

This final section will synthesize the main evidence gaps, including limitations noted by researchers, such as study heterogeneity, challenges in adherence, and areas where more targeted research is still needed.

Data for certain groups remain insufficient. For instance, evidence specifically exploring the use in pregnant or breastfeeding populations is limited. Additionally, findings from older adults with complex comorbidities may require careful interpretation, as the results apply only to the populations studied.

Furthermore, limited comparative research exists for many head-to-head comparisons against other topical therapies. The potential influence of patient adherence on outcomes is a recognized limitation, as study results reflect the specific conditions under which they were conducted.

Key Studies & References

  1. Petrolatum: Uses, Interactions, Mechanism of Action | DrugBank Online (Monograph for Occlusive Agents)
  2. Current approach to moisturizer and emollient utilization in atopic dermatitis: a review

Frequently Asked Questions (FAQ)

Common questions about Dermeze (FAQ)


Q: What exactly is the active ingredient in Dermeze, and what does it do?

A: The primary active ingredients in Dermeze are White Soft Paraffin (Petrolatum) and Liquid Paraffin (Mineral Oil). These components work as occlusive emollients. Their physical action is to form a continuous, water-resistant layer on the skin's surface, which helps to minimize the natural loss of moisture from the skin.


Q: Why does Dermeze feel greasy when applied?

A: The sensation described as 'greasy' is a characteristic of its primary function. Official information indicates that, as an occlusive emollient, Dermeze is designed to form a substantial, protective physical barrier on the skin. This barrier helps seal in moisture but results in a highly adherent, film-like texture.


Q: Are there any known medications that can't be used at the same time as Dermeze?

A: Dermeze has no documented systemic interactions with oral medicines because it is not absorbed into the bloodstream. However, its physical barrier effect may affect how other topical medicines are absorbed. Official guidance indicates that separating the application of emollients and other topical medicinal products by approximately 20 to 30 minutes may be necessary.


Q: Can Dermeze be used on skin that is already broken or irritated?

A: Official regulatory documentation provides specific restrictions on application. The product is not intended for use on skin that is infected, weeping, broken, or severely damaged, based on regulatory contraindications.


Q: Why do some people use Dermeze as a cleanser or soap substitute?

A: Some Dermeze product types are specifically formulated and officially designated for use as soap-free washes or cleansers. The simple, purified paraffin base is also commonly utilized as a substitute for traditional soap. This helps sensitive skin to be cleansed while avoiding the drying effects that can be associated with standard soaps.


Q: Why are people discussing Dermeze in forums about managing psoriasis?

A: While Dermeze is officially indicated for dry skin conditions like xerosis and atopic dermatitis, emollients are broadly used in dermatology as supportive therapy. Official information suggests that occlusive products are used as supportive care in various dry skin conditions, including psoriasis, to help maintain hydration.


Q: Can Dermeze be used alongside topical steroid creams?

A: Official guidance indicates that emollients are often used with topical steroid creams. To help ensure the steroid works as intended, regulatory guidance recommends a time separation of 20 to 30 minutes between the applications of the emollient and the steroid cream.


Q: Can Dermeze be used to prevent skin dryness, not just treat it?

A: The official instructions indicate that Dermeze is suitable for continuous, long-term use. This usage pattern is consistent with maintaining functional skin stability, which is often considered supportive care for preventing the recurrence of dryness.


Q: Does the application of Dermeze need to be rubbed in completely?

A: The instructions direct users to apply a liberal amount, enough to create a continuous occlusive layer. The main objective is to form a physical barrier on the skin's surface to reduce water loss; the application process is focused on achieving this seal rather than ensuring full absorption.


Q: What is the main difference between Dermeze and regular moisturizing creams?

A: Dermeze is formally classified as an occlusive emollient, primarily composed of purified paraffin. This composition creates a dense, physical film that is highly effective at blocking water loss (occlusion). This physical, barrier-forming action is the key factor that distinguishes it from many lighter, non-occlusive moisturizing lotions.


Q: Is Dermeze safe to use on my face every day?

A: The product is designed for external, topical use on all age groups, and certain formulations (like the cream) are described as highly skin-tolerant and suitable for use on the face. Its simple, purified formula is consistent with application on a daily basis as required.


Q: I have sensitive skin; is Dermeze less likely to cause irritation than other products?

A: Official information indicates the formulation is based on simple, purified paraffin and is free from common irritants such as fragrances and parabens. Its composition is described in product labeling as minimizing the risk of irritation, making it suitable for sensitive skin.


Q: Does Dermeze contain steroids or parabens?

A: Official labeling for Dermeze states that the product is formulated to be paraben-free. Furthermore, as a non-prescription emollient, its composition does not contain steroids.


Q: Can Dermeze cause an allergic reaction, and what are the signs?

A: Hypersensitivity reactions are listed as a rare adverse effect in official safety data. Signs of a serious allergic reaction, which is extremely rare, can include symptoms like swelling of the face, difficulty breathing, or the outbreak of hives. Such signs are reported in official data as requiring urgent medical attention.


Q: Is it normal for Dermeze to have a slight smell?

A: Dermeze is officially described as fragrance-free on its label, meaning no perfume or scent is added to the formulation. Any faint odor that may be present is solely due to the natural characteristics of the purified raw ingredients.


Q: Is Dermeze safe to apply to the scalp or near the eyes?

A: Dermeze is intended for topical application to the skin. While there are no specific warnings against use on the scalp, it is a standard precaution that the product is not used in the immediate eye area.


Q: Does Dermeze contain any ingredients derived from nuts or common allergens?

A: The product's formulation is simple, based on purified paraffins. Official labeling highlights that the product is free of common allergens such as gluten and lanolin, reflecting its simple and highly tolerant composition.


Q: What are the differences between the various Dermeze product types (if applicable)?

A: Dermeze is commonly offered in different pharmaceutical forms, such as an Ointment and a Cream. Official information indicates the Ointment typically provides the maximum occlusive barrier for very dry skin, while the Cream is a lighter, water-based formulation for easier spreading and general hydration needs.


How should Dermeze be stored and disposed of?

Official Storage and Disposal Requirements

Regulatory documentation defines specific rules for storing and handling Dermeze to maintain its stability and ensure safety. This product must be stored at a controlled room temperature, typically below 25 C or 30 C, and kept away from direct sunlight. It is mandatory not to freeze the product.

Handling and Safety Constraints

Requirement Official Statement
Temperature Store below 25 C / 30 C.
Freezing Do not freeze.
Child Safety Keep out of reach of children.
Flammability Ointment absorbed onto materials (like clothing or dressings) in large quantities can increase their flammability.

No explicit instructions are typically provided in official labeling regarding the general disposal of expired or unused portions via household waste or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Dermeze found in:

A-Z Index: